Biotech Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome August 28, 2026
Biotech BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals August 28, 2026
Biotech Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million August 28, 2026
Biotech HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma August 27, 2026
Biotech AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease August 26, 2026
Biotech Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases August 26, 2026
Biotech Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy August 26, 2026
Biotech Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options August 25, 2026
Biotech CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors August 25, 2026
Search
Biotech
August 28, 2026
August 28, 2026
August 28, 2026
August 27, 2026
August 26, 2026
August 26, 2026
August 26, 2026
August 26, 2026
August 25, 2026
August 25, 2026
